Details

Autor(en) / Beteiligte

• Kalemkerian, Gregory P
• Akerley, Wallace
• Bogner, Paul
• Borghaei, Hossein
• Chow, Laura Qm
• Downey, Robert J
• Gandhi, Leena
• Ganti, Apar Kishor P
• Govindan, Ramaswamy
• Grecula, John C
• Hayman, James
• Heist, Rebecca Suk
• Horn, Leora
• Jahan, Thierry
• Koczywas, Marianna
• Loo, Jr, Billy W
• Merritt, Robert E
• Moran, Cesar A
• Niell, Harvey B
• O'Malley, Janis
• Patel, Jyoti D
• Ready, Neal
• Rudin, Charles M
• Williams, Jr, Charles C
• Gregory, Kristina
• Hughes, Miranda

Titel

Small cell lung cancer

Ist Teil von

• Journal of the National Comprehensive Cancer Network, 2013-01, Vol.11 (1), p.78-98

Ort / Verlag

United States

Erscheinungsjahr

2013

Quelle

MEDLINE

Beschreibungen/Notizen

• Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted.